Rebitschek, F. G., Pashayan, N., Widschwendter, M., & Wegwarth, O. (2019). Do cancer risk and benefit-harm ratios influence women's consideration of risk-reducing mastectomy? A scenario-based experiment in five European countries. PLoS ONE, 14(6), Article e0218188. https://doi.org/10.1371/journal.pone.0218188

Rebitschek, F. G., Reisel, D., Lein, I., & Wegwarth, O. (2019). Epigenetic risk assessment of female cancers: Women's information needs and attitudes. Public Health Genomics, 22(1-2), 46–57. https://doi.org/10.1159/000501975

Wegwarth, O., Pashayan, N., Widschwendter, M., & Rebitschek, F. G. (2019). Women's perception, attitudes, and intended behavior towards predictive epigenetic risk testing for female cancers in 5 European countries: A cross-sectional online survey. BMC Public Health, 19, Article 667. https://doi.org/10.1186/s12889-019-6994-8

Mühlbauer, V., Prinz, R., Mühlhauser, I., & Wegwarth, O. (2018). Alternative package leaflets improve people's understanding of drug side effects - A randomized controlled exploratory survey. PLoS ONE, 13(9), Article e0203800. https://doi.org/10.1371/journal.pone.0203800

Wegwarth, O. (2018). Brustkrebsfrüherkennung - Nutzen und Risiken richtig kommunizieren. Der Gynäkologe, 51(5), 370–379. https://doi.org/10.1007/s00129-018-4199-3

Wegwarth, O., & Gigerenzer, G. (2018). US gynecologists' estimates and beliefs regarding ovarian cancer screening's effectiveness 5 years after release of the PLCO evidence. Scientific Reports, 8, Article 17181. https://doi.org/10.1038/s41598-018-35585-z

Wegwarth, O., Widschwendter, M., Cibula, D., Sundström, K., Portuesi, R., Lein, I., Rebitschek, F. G., & FORECEE (4C) Consortium. (2018). What do European women know about their female cancer risks and cancer screening? A cross-sectional online intervention survey in five European countries. BMJ Open, 8, Article e023789. https://doi.org/10.1136/bmjopen-2018-023789

Widschwendter, M., Jones, A., Evans, I., Reisel, D., Dillner, J., Sundström, K., Steyerberg, E. W., Vergouwe, Y., Wegwarth, O., Rebitschek, F. G., Siebert, U., Sroczynski, G., de Beaufort, I. D., Bolt, I., Cibula, D., Zikan, M., Bjørge, L., Colombo, N., Harbeck, N., Dudbridge, F., Tasse, A.-M., Knoppers, B. M., Joly, Y., Teschendorff, A. E., Pashayan, N., & the FORECEE (4C) Consortium. (2018). Epigenome-based cancer risk prediction: Rationale, opportunities and challenges. Nature Reviews Clinical Oncology, 15(5), 292–309. https://doi.org/10.1038/nrclinonc.2018.30

Donner-Banzhoff, N., Seidel, J., Sikeler, A. M., Bösner, S., Vogelmeier, M., Westram, A., Feufel, M., Gaissmaier, W., Wegwarth, O., & Gigerenzer, G. (2017). The phenomenology of the diagnostic process: A primary-care based survey. Medical Decision Making, 37(1), 27–34. https://doi.org/10.1177/0272989X16653401

Wegwarth, O., Wagner, G. G., & Gigerenzer, G. (2017). Can facts trump unconditional trust? Evidence-based information halves the influence of physicians' non-evidence-based cancer screening recommendations. PLoS ONE, 12(8), Article e0183024. https://doi.org/10.1371/journal.pone.0183024

McDowell, M., Rebitschek, F. G., Gigerenzer, G., & Wegwarth, O. (2016). A simple tool for communicating the benefits and harms of health interventions: A guide for creating a fact box. MDM Policy & Practice, 1, Article 2381468316665365. https://doi.org/10.1177/2381468316665365

Prinz, R., Feufel, M. A., Gigerenzer, G., & Wegwarth, O. (2015). What counselors tell low-risk clients about HIV test performance. Current HIV Research, 13(5), 369–380. https://doi.org/10.2174/1570162X13666150511125200

Wegwarth, O. (2015). Medizinische Risikokommunikation: Nutzen und Schaden transparent kommunizieren. Forum: Das Offizielle Magazin der Deutschen Krebsgesellschaft e. V., 30(3), 208–213. https://doi.org/10.1007/s12312-015-1303-7

Wegwarth, O. (2015). Cancer survival rates: The CONCORD-2 study. The Lancet, 386(9992), 429–429. https://doi.org/10.1016/S0140-6736(15)61442-8

Wegwarth, O. (2014). Transparent risk communication in cancer screening: Reveal when it's good and when it's not. Oncology Research and Treatment, 37(Suppl. 3), 6–7. https://doi.org/10.1159/000367912

Wegwarth, O., & Gigerenzer, G. (2014). Improving evidence-based practices through health literacy - in reply. JAMA Internal Medicine, 174(8), 1413–1414. https://doi.org/10.1001/jamainternmed.2014.846

Wegwarth, O., Kurzenhäuser-Carstens, S., & Gigerenzer, G. (2014). Overcoming the knowledge-behavior gap: The effect of evidence-based HPV vaccination leaflets on understanding, intention, and actual vaccination decision. Vaccine, 32(12), 1388–1393. https://doi.org/10.1016/j.vaccine.2013.12.038

Wegwarth, O., & Prinz, R. (2014). Risikokommunikation: Medizinische Risiken verstehen und verständlich machen. Zentralblatt fur Arbeitsmedizin, Arbeitsschutz und Ergonomie, 64(5), 320–324. https://doi.org/10.1007/s40664-014-0053-1

Gigerenzer, G., & Wegwarth, O. (2013). Five year survival rates can mislead. BMJ, 346, Article f548. https://doi.org/10.1136/bmj.f548

Wegwarth, O. (2013). Statistical illiteracy in residents: What they do not learn today will hurt their patients tomorrow. Journal of Graduate Medical Education, 5(2), 340–341. https://doi.org/10.4300/JGME-D-13-00084.1